No Controversy Here
While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.
Related Articles
Revolutionary Technology for Cardiac Patients
For the first time in Israel, at the Catheterization Institute at Rabin Medical Center, a revolutionary heart catheterization procedure was performed using soluble stents.
21st Century Medical Achievements
Israel's Rabin Medical Center has always set the highest standard in medical care, pioneering advanced technologies and state of the art equipment to provide the most effective treatments while maintaining its commitment to compassionate care for patients and their families, treating them with humanity and preserving their dignity.